Event  

Breakfast seminar coming up 7/3 - Cancer immunotherapy

2019.02.08

The 2018 Nobel prize, leading Swedish research today and impacts on patients tomorrows.

Cancer is the world’s second largest cause of death, according to the Nobel Assembly. Until recently, cancer treatment has relied on four options: surgery, radiation, chemotherapy and targeted therapy. The success of immunotherapy has emerged as a new fifth pillar by some defined as a new era in the treatment of cancer.

In December 2018, two immunologists—American James Allison and Japan’s Tasuku Honjo — were awarded the Nobel Prize in medicine for pioneering a way to re-program a person’s immune system to attack cancer cells.

In this seminar Klas Kärre (professor at KI and member of the Nobel Committee) will explain Allison’s and Hoino’s research as well as previous research by others in this field that may offer new opportunities today.

In this seminar we will also present Swedish research in the field today. Hans Gustav-Ljunggren (professor at KI and member of the Nobel Committee) will share his insights in the development of new cell based therapies (with a focus on NK cells), and associate professor Alex Karlsson-Parra (Chief Scientific Officer at Immunicum AB) will present Immunicum’s lead development candidate (ilixandencel) using specifically activated dendritic cells for treating cancer.
We hope you are able to join us for a discussion of a very interesting field of research and development that may offer promising opportunities for Swedish life sciences!

Date
Thursday 7 March 2019.

Time
Breakfast will be served from 07.30 and presentations are expected to start at 08.00 and end around 09.30.

Location
At Cirio Advokatbyrå, Mäster Samuelsgatan 20, 8th floor

SIGN UP HERE.

Per Hedman
Partner
email hidden; JavaScript is required
+46 76 617 09 21

Expertise